These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15980409)

  • 21. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Ross JJ; Worthington MG; Gorbach SL
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12097545
    [No Abstract]   [Full Text] [Related]  

  • 22. Changing trends in antimicrobial-resistant pneumococci: it's not all bad news.
    Low DE
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S228-33. PubMed ID: 16032557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
    Balkhy HH; Memish ZA; Shibl A; Elbashier A; Osoba A
    East Mediterr Health J; 2005; 11(1-2):36-44. PubMed ID: 16532669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal serotypes and virulence.
    Musher DM
    J Infect Dis; 2006 Feb; 193(3):477; author reply 477-8. PubMed ID: 16388500
    [No Abstract]   [Full Text] [Related]  

  • 25. Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Yokota S; Ohkoshi Y; Fujii N
    Diagn Microbiol Infect Dis; 2009 Sep; 65(1):76-80. PubMed ID: 19679241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model.
    Reed JM; O'Callaghan RJ; Girgis DO; McCormick CC; Caballero AR; Marquart ME
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):604-8. PubMed ID: 15671288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans.
    Sandgren A; Albiger B; Orihuela CJ; Tuomanen E; Normark S; Henriques-Normark B
    J Infect Dis; 2005 Sep; 192(5):791-800. PubMed ID: 16088828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.
    Ip M; Chau SS; Chi F; Cheuk ES; Ma H; Lai RW; Chan PK
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2192-4. PubMed ID: 17371818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of vancomycin plus levofloxacin combination therapy for refractory pericarditis due to multiresistant Streptococcus pneumoniae.
    Safdar A
    Int J Infect Dis; 2003 Dec; 7(4):287. PubMed ID: 14656421
    [No Abstract]   [Full Text] [Related]  

  • 31. Enhanced decrease of blood colony counts by specific anti-pneumococcal antibodies in the presence of sub-inhibitory concentrations of amoxicillin.
    Yuste J; Giménez MJ; Jado I; Fenoll A; Aguilar L; Casal J
    J Antimicrob Chemother; 2001 Oct; 48(4):594-5. PubMed ID: 11581248
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunization and antimicrobials. Is there an association between the effects against Streptococcus pneumoniae?].
    Aguilar L; Giménez MJ
    Rev Esp Quimioter; 2007 Mar; 20(1):125-7. PubMed ID: 17530045
    [No Abstract]   [Full Text] [Related]  

  • 33. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
    Mohler J; Moine P; Azoulay-Dupuis E; Henin D; Fantin B
    Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA.
    He X; McDaniel LS
    FEMS Microbiol Lett; 2007 Apr; 269(2):189-95. PubMed ID: 17355599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Streptococcus pneumoniae infection].
    Tateda K
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():323-9. PubMed ID: 12722237
    [No Abstract]   [Full Text] [Related]  

  • 36. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
    Schentag JJ; Klugman KP; Yu VL; Adelman MH; Wilton GJ; Chiou CC; Patel M; Lavin B; Paladino JA
    Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new pneumococcus type. Type 12A.
    Lund E; Munksgaard A
    Acta Pathol Microbiol Scand; 1967; 70(2):305-10. PubMed ID: 4383090
    [No Abstract]   [Full Text] [Related]  

  • 38. Capsular type and the pneumococcal human host-parasite relationship.
    Crook DW
    Clin Infect Dis; 2006 Feb; 42(4):460-2. PubMed ID: 16421788
    [No Abstract]   [Full Text] [Related]  

  • 39. Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones.
    Huelves L; Sevillano D; Martínez-Marín C; López-Casla MT; Gracia M; Alou L; del Carmen Ponte M; Prieto J; Soriano F;
    Int J Antimicrob Agents; 2006 Apr; 27(4):294-9. PubMed ID: 16527462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
    Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.